Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real-world efficacy.

Kenya is one of nine African countries selected for the initial rollout of lenacapavir (LEN), a new injectable drug for human immunodeficiency virus (HIV) prevention, scheduled for January 2026.

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Patients with HIV who were more impacted by health disparities were less likely to find long-acting injectable antiretroviral therapy appealing. LAI-ART is a novel tool that can be used to treat PWH ...

Aadia Rana, M.D., professor of medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham, senior scientist with the UAB Center for AIDS Research and study chair for ...

There's no vaccine for HIV, the virus that can lead to AIDS. And stories about people being cured of HIV are still read as miracles. HIV can, however, be prevented, controlled and treated with tablets ...

Lenacapavir, a twice-yearly injectable antiretroviral, demonstrated 100% effectiveness for preventing HIV acquisition in a large study of young cisgender women in Africa, Gilead Sciences announced ...

Colorized transmission electron micrograph of two HIV-1 virus particles (red/yellow) budding from the plasma membrane of an H9 T cell (teal). Image captured at the NIAID Integrated Research Facility ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...

Antiretroviral therapy (ART) intramuscularly administered may have the same effectiveness as current oral treatments. This is the main conclusion of the Phase II clinical trial carried out by 50 ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...